Skip to main content
. 2021 Jun 9;8:668534. doi: 10.3389/fmolb.2021.668534

FIGURE 6.

FIGURE 6

Fold change of miR-10b (A) and miR-155 (B) in the plasma of TNBC according to relapse status. (C). ROC curve analysis depicting the ability of 2-miRNA panel consisted of miR-126 and miR-155 expression to predict relapsed from non- relapsed patients into TNBC sub-group. TNBC, triple negative breast cancer; AUC, area under curve.